← Open Payments lookup

LISA CHAPMAN: Open Payments

NPI 1265189336 · MANSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$404 in 22 payments from 7 companies in 2025. Trend: 2023 $150 · 2024 $895 · 2025 $404

Food & beverage: $404
CompanyPaymentsAmount
Alkermes, Inc.10$159
Otsuka America Pharmaceutical, Inc.5$101
ABBVIE INC.2$46
Sage Therapeutics, LLC1$33
Neurocrine BioSciences, Inc.2$30
Supernus Pharmaceuticals, Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: ARISTADA, REXULTI, VRAYLAR, ZURZUVAE, INGREZZA, Qelbree, CAPLYTA.

Industry payments across MA — which companies pay providers there.